Advertisement
Research Article Free access | 10.1172/JCI116574
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver 80262.
Find articles by Pietropaolo, M. in: JCI | PubMed | Google Scholar
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver 80262.
Find articles by Castaño, L. in: JCI | PubMed | Google Scholar
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver 80262.
Find articles by Babu, S. in: JCI | PubMed | Google Scholar
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver 80262.
Find articles by Buelow, R. in: JCI | PubMed | Google Scholar
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver 80262.
Find articles by Kuo, Y. in: JCI | PubMed | Google Scholar
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver 80262.
Find articles by Martin, S. in: JCI | PubMed | Google Scholar
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver 80262.
Find articles by Martin, A. in: JCI | PubMed | Google Scholar
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver 80262.
Find articles by Powers, A. in: JCI | PubMed | Google Scholar
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver 80262.
Find articles by Prochazka, M. in: JCI | PubMed | Google Scholar
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Science Center, Denver 80262.
Find articles by Naggert, J. in: JCI | PubMed | Google Scholar
Published July 1, 1993 - More info
We have identified a novel 69-kD peptide autoantigen (ICA69) associated with insulin-dependent diabetes mellitus (IDDM) by screening a human islet lambda gt11 cDNA expression library with cytoplasmic islet cell antibody positive sera from relatives of IDDM patients who progressed to the overt disease. The deduced open reading frame of the ICA69 cDNA predicts a 483-amino acid protein. ICA69 shows no nucleotide or amino acid sequence relation to any known sequence in GenBank, except for two short regions of similarity with BSA. The ICA69 cDNA probe hybridizes with a 2-kb mRNA in poly(A+) RNA from human pancreas, brain, heart, thyroid, and kidney, but not with skeletal muscle, placenta, spleen, or ovary. Expression of ICA69 was also detected in beta cells and cell lines, as well as in tumoral tissue of islet cell origin. The native ICA69 molecule migrates to 69 kD in SDS-PAGE as detected with specific antibodies. Serum samples from relatives of IDDM patients specifically reacted with affinity-purified recombinant ICA69 on Western blotting. The structural gene for ICA69 was designated ICA1. A homologue in the mouse, designated Ica-1 was mapped to the proximal end of chromosome 6 (within 6 cM of the Met protooncogene). ICA69 adds a novel autoantigen to the family of identified islet target molecules, and by the manner of its identification and characterization large amounts of antigen are available for development of quantitative, convenient predictive assays for autoantibodies and analysis of the role of this molecule in diabetes autoimmunity, as well as its physiologic function.
Images.